MYGN Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $18.42 = $184.2
MYGN Charts
MYGN Prices
View the MYGN historical prices.
52WL $13.82
The 52 Week Low is $13.82 set on Fri, Apr 19, 2024.
52WH $24.21
The 52 Week High is $24.21 set on Fri, Apr 19, 2024. The current price, $18.42, is 0% below the 52 Week High.
ATH $0.00
The All-Time High is $0.00 set on Fri, Apr 19, 2024. The current price, $18.42, is 0% below the All Time High.
52 Week Range
MYGN Dividends
MYGN has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
MYGN Profile
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
